ITMN 10.73 0.54 / InterMune, Inc. News | Benzinga

Monday, May 21, 2012

Intermune Will Divest Rights to Vidara for $55M in Cash, Plus 2 Year Royalty Stream (ITMN, News, Asset Sales, FDA / Mon, 04:52pm)

Thursday, April 05, 2012

France's Transparency Commission (CT) Issues Favorable Opinion for Reimbursement of Esbriet; Intermune Expresses Confidence In Ascend Phase 3 Study Outcome; Updates Timeline (ITMN, News, Contracts, FDA / Thu, 01:31pm)

Thursday, March 15, 2012

G-BA Issues 4-Rating on InterMune's Esbriet, Jefferies Maintains Underform (Analyst Color, ITMN, News, Reiteration, Events, Global, Analyst Ratings / Thu, 11:29am)
Morning Social Media Outlook for Thursday March 15 (ITMN, CSCO, MET, GES) (AAPL, BAC, C, CSCO, Earnings, GES, GOOG, GS, ITMN, MET, News, Guidance, Global, Economics, Tech, Trading Ideas / Thu, 10:17am)
Intermune Up 17% After German Agency Says Esbriet Offers Benefit (ITMN, News, FDA, Intraday Update, Movers / Thu, 09:58am)
Esbriet (pirfenidone) Benefit Granted by German Federal Joint Committee (ITMN, News, FDA, Global / Thu, 08:14am)

Monday, January 09, 2012

Just What The Doctor Ordered: 4 ETFs For Biotech M&A (ACHN, AFFX, ALXN, AMGN, BBH, BIIB, BMRN, BMY, CELG, DNDN, FBT, GILD, IDIX, INHX, ITMN, Long Ideas, News, PSCH, REGN, Sector ETFs, XBI, Short Ideas, Specialty ETFs, New ETFs, Rumors, Small Cap Analysis, Technicals, FDA, M&A, Events, Intraday Update, After-Hours Center, Markets, Movers, Trading Ideas, ETFs / Mon, 04:49pm)

Friday, January 06, 2012

Goldman Reiterates Neutral On InterMune, Lowers PT (Analyst Color, ITMN, News, Price Target, Reiteration, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Fri, 01:39pm)

Thursday, January 05, 2012

InterMune Reports Preliminary Fourth Quarter 2011 Esbriet Revenue and Other Recent Business Highlights (Earnings, IPF, ITMN, News, NPP, FDA / Thu, 08:03am)

Friday, December 16, 2011

IQWIG Publishes Early Benefit Assessment for Pirfenidone (ITMN, News, FDA / Fri, 07:55am)

Thursday, December 15, 2011

Benzinga's M&A Chatter for Thursday December 15, 2011 (AEO, ALXN, BHP, CRYP, DNDN, EK, HGSI, INCY, ITMN, KKR, Long Ideas, MNTA, News, ONXX, RIO, SGEN, SONO, SWI, VRTX, WLT, Short Ideas, Rumors, Asset Sales, M&A, After-Hours Center, Movers, Tech, Trading Ideas, General / Thu, 06:47pm)
End-of-Day Market Summary for December 15, 2011 (BWA, C, CVC, DMND, HOLX, ITMN, NBG, News, NSU, NVLS, SONO, TE, XYL, ZOLL, Broad U.S. Equity ETFs, Upgrades, Downgrades, Events, Global, Econ #s, Economics, After-Hours Center, Markets, Analyst Ratings, Movers, Tech, Reviews, ETFs / Thu, 05:29pm)
Afternoon Movers; Markets Moved Higher (ITMN, NBG, News, NSU, NVLS, SONO, ZOLL, Broad U.S. Equity ETFs, Events, Economics, After-Hours Center, Markets, Movers, Tech, Reviews, ETFs / Thu, 05:08pm)
UPDATE: German Science Board that Contracts with Government Raises Doubt about Pirfenidone Benefit (ITMN, News, Rumors, FDA, Global, Movers / Thu, 12:21pm)

Tuesday, September 13, 2011

US Stock Futures Signal Weaker Start On Wall Street (BBY, CBRL, ISIL, ITMN, News, WNI, Futures, Global, Pre-Market Outlook, Markets / Tue, 06:13am)
Stocks To Watch For September 13 (BBY, CBRL, Earnings, ISIL, ITMN, News, SPWRB, Guidance, Offerings, Pre-Market Outlook, Markets, Trading Ideas / Tue, 03:45am)

Monday, September 12, 2011

UPDATE: InterMune Announces Proposed Concurrent Public Offerings, 4M Shares of Common Stock and $100M Convertible Debt Senior Notes (ITMN, News, Financing, Offerings / Mon, 04:33pm)
InterMune Announces Launch of Esbriet in Germany (ITMN, News, FDA / Mon, 07:00am)

Thursday, July 07, 2011

InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF (ITMN, News, FDA / Thu, 07:10pm)

Wednesday, May 25, 2011

InterMune to Provide Overview of Corporate Strategy; Sees R&D Expenses of $85-$95 Million (ITMN, News, Guidance / Wed, 04:01pm)

Monday, May 16, 2011

Intermune Announces Presentation Of Positive Pirfenidone Data At The International Conference Of The American Thoracic Society (ITMN, News, FDA / Mon, 07:20am)

Tuesday, May 10, 2011

Top Percentage Gainers and Losers as of 12pm 5/10/11 (FONR, TRAK, CKXE, CPE, FFHL MED, PTRY, GENE,BMTI, HEAT, PANL, USAT, HOLI, ITMN, VRML) (BMTI, CKXE, CPE, Earnings, FFHL, FONR, GENE, HEAT, HOLI, ITMN, Long Ideas, MED, News, PANL, PTRY, TRAK, USAT, VRML, Short Ideas, Small Cap Analysis, Technicals, Intraday Update, Markets, Movers, Trading Ideas / Tue, 12:06pm)
UPDATE: Intermune Holder Warburg has 16.07% Stake in Company, Considering Selling (ITMN) -Bloomberg (ITMN, News, Asset Sales / Tue, 08:50am)
Intermune Holder Warburg Has 16.07% Stake In Company (ITMN) -Bloomberg (ITMN, News / Tue, 08:41am)

Thursday, April 28, 2011

Benzinga's Top Pre-Market NASDAQ Losers (AKAM, FLEX, MLNX, ITMN) (AKAM, FLEX, ITMN, MLNX, News, Pre-Market Outlook, Intraday Update, Markets / Thu, 08:19am)

Tuesday, April 12, 2011

Unconfirmed Rumors circulate that (ITMN) has been offered $60.00 a share other side unknown (ITMN, News, Rumors, M&A / Tue, 09:36am)

Friday, December 17, 2010

InterMune Continues To Skyrocket (ITMN) (CHMP, ITMN, News, FDA, Movers / Fri, 03:57pm)

Thursday, October 28, 2010

InterMune Reports Third Quarter EPS of $(0.44) (Earnings, ITMN, News / Thu, 04:07pm)

Wednesday, October 27, 2010

Merck In Talks To Acquire InterMune (MRK, ITMN) (ITMN, MRK, News, Rumors, M&A / Wed, 03:25pm)

Thursday, October 07, 2010

Benzinga's Volume Movers (EQIX, TTES, BMC, ITMN) (BMC, EQIX, ITMN, Long Ideas, News, RHHBY, TTES, Intraday Update, Markets, Movers, Trading Ideas / Thu, 12:18pm)
InterMune Divests Danoprevir (Analyst Color, IPF, ITMN, News, Price Target, Analyst Ratings / Thu, 10:10am)
Benzinga's Top Pre-Market NASDAQ Gainers (ALVR, ITMN, FSLR, AKRX) (AKRX, ALVR, FSLR, ITMN, Long Ideas, News, RHHBY, Pre-Market Outlook, Intraday Update, Markets, Trading Ideas / Thu, 08:29am)

Wednesday, October 06, 2010

Benzinga's After Hours Movers (ITMN, BLUD, WFR, MAR) (BLUD, Earnings, ITMN, MAR, News, WFR, Intraday Update, Movers / Wed, 08:11pm)
InterMune Sells Danoprevir Rights to Roche for $175 Million (ITMN, News, Contracts, Tech / Wed, 04:03pm)

Tuesday, August 31, 2010

InterMune Inc. (ITMN) -- Pirfenidone European APPROVAL indicated !!! - Consultant Stock to trade over USD $50 per share on EMEA approval as European market 2 times bigger than US.Unconfirmed Rumor. (ITMN, News, Rumors, M&A, Movers / Tue, 10:11am)

Tuesday, August 24, 2010

(ITMN) Unconfirmed rumor positive news from FDA coming (ITMN, News, Rumors, M&A, Markets / Tue, 10:08am)